Form 4: Amgen CFO Peter Griffith Reports Stock Disposition

Amgen Inc. EVP and CFO Peter H. Griffith reported the disposition of 556 shares of common stock to cover tax obligations.

Summary

• Peter H. Griffith, EVP and CFO of Amgen Inc., disposed of 556 shares of common stock on May 7, 2026.
• The transaction was executed at a price of $331.11 per share.
• The disposition was made to satisfy tax withholding obligations related to the vesting of equity awards.
• Following this transaction, the reporting person maintains beneficial ownership of 50,150 shares of Amgen common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a routine administrative action for tax purposes rather than a discretionary sale.

Positives

• The reporting person retains a significant equity stake of 50,150 shares, aligning interests with shareholders.

Negatives

• The transaction represents a reduction in the direct holdings of a key executive.

Risks

• None identified; this is a routine administrative transaction related to tax withholding.

Future Outlook

Not applicable; this is a retrospective disclosure of an insider transaction.

Industry Context

StockSavvy.ai notes that routine tax-related dispositions by C-suite executives are standard practice in the biotechnology sector and generally do not signal a change in management's outlook on company performance.

Comparison to Industry Standards

• The transaction is consistent with standard executive compensation and tax withholding practices observed at large-cap pharmaceutical companies like Pfizer, Merck, and Gilead Sciences.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard tax-related equity settlement.

Key Dates

Keywords

Amgen, AMGN, Insider Trading, Form 4, CFO, Equity Compensation